Acamprosate in the Treatment of Binge-Eating Disorder

NCT00511940 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Binge Eating Disorder

Interventions

DRUG: acamprosate
OTHER: placebo

Sponsor

Lindner Center of HOPE

Collaborators

[object Object]
[object Object]